reggie

About reggie

This author has not yet filled in any details.
So far reggie has created 36 blog entries.

How can our society study and regulate the offerings of popular, but unproven, regenerative medicine?

Advances have been made in the field of stem cell therapy, but the expansion of therapies offered, some with, some without, a deep level of research, has grown significantly. Many Americans are traveling to other countries with less rigorous testing requirements to access these therapies. But because the range of the available unproven treatments is [...]

December 8, 2017|General|0 Comments

One patient’s story: How WCGF helped speed approval for experimental treatment

It took more than two years for Tyson Fowler to receive an accurate diagnosis of the cause of his motor neuron symptoms. By then, chronic Lyme disease had taken its toll. The once healthy, athletic 30-something was confined to a wheelchair, unable to move on his own. His condition was worsening rapidly, and the prognosis was grim.

December 6, 2017|News|0 Comments

How did physicians use a discovery from a recent #clinicaltrial to save the life of a boy with a dangerous skin condition?

Using a discovery involving the boy’s own stem cells, physicians were able to save the life of a boy with a dangerous genetic skin condition. The patient, who was suffering from junctional epidermolysis bullosa, in which the skin sheds the epidermis, had lost over eighty percent of his top layer of skin. Through the growth [...]

December 5, 2017|General|0 Comments

How is the FDA widening the scope of the Reagan Udall Expanded Access Navigator to assist patients with rare or orphan diseases?

Patients with rare diseases face unique challenges. Often, there may be no FDA approved treatments for them, or the patient population with an orphan disease is very small – it may be difficult to find clinical trials developing medicine for their diseases. For this reason, the FDA is expanding the use of the Reagan-Udall Foundation’s [...]

December 1, 2017|General|0 Comments

How can you further WCGF’s mission to educate, include and provide access?

Today is Giving Tuesday - a day to remember that much of the good in the world is undertaken by not-for-profit organizations. WCG Foundation's goals in expanded access, ethical training for medical research professionals, and encouraging greater minority participation in clinical trials, are supported by good people - donors make the difference. Please give today [...]

November 28, 2017|General|0 Comments

For heart attack patients unwilling to enroll in traditional rehabilitation programs, what could be a good alternative?

The American Heart Association has recently reported a study in which patients who have suffered a heart attack, and were unwilling or unable to enroll in cardiac rehabilitation programs, had success with tai chi. Those in the group of patients who were attending tai chi practices more often performed more moderate-to-vigorous physical activity over a [...]

November 24, 2017|General|0 Comments

How can immunotherapies for cancer treatment be further developed and encouraged?

The NIH and a consortium of biotechnical companies have created PACT, or the Partnership for Accelerating Cancer Therapies, to encourage the development of new immune based treatments for cancer. In some types of cancer, immunotherapies have created dramatic change in the success of treatment. Who is involved in PACT? And what are its goals? http://bit.ly/2xB85zR

November 21, 2017|General|0 Comments

Can expanded access give insight into the future success or failure of a new treatment?

As patients who are receiving treatments via expanded access for diseases are outside of the controlled environment of a clinical trial, their experiences may be considered to be more "real-world." A multi-national chart review has shown that the success of treatments given through expanded access was mirrored in clinical trials, then after approval and mass [...]

November 17, 2017|General|0 Comments

How could research of stem cells improve the delivery of cancer drugs to metastatic tumors?

Recent research of stem cells in mice has produced a more precise way to deliver chemotherapy to the tumor microenvironment of metastatic cancer. As opposed to targeting cancer cells directly, as other stem cell research has aimed to achieve, this delivery method targets the cells in their home, which could have a greater effect on [...]

November 14, 2017|General|0 Comments

Could wider inclusion of minority patients in clinical trials actually lower the cost of healthcare overall?

Lack of accurate data regarding potential side effects or differences in effectiveness in treatments between white Americans and patients of different ethnic backgrounds often leads to less affordable options of care. When drugs have been studied, and minorities left out, treatments that are less effective could lead to greater numbers of hospitalizations, driving up the [...]

November 10, 2017|General|0 Comments